Randomized, Double-blind, Placebo-controlled, Phase I Dose-escalation Study of Single Dose GHB01L1 in Healthy Volunteers (GHBCS-01)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00724997
Recruitment Status : Completed
First Posted : July 30, 2008
Last Update Posted : December 8, 2009
Information provided by:
AVIR Green Hills Biotechnology AG